Nature Communications (Sep 2016)

The lncRNA landscape of breast cancer reveals a role for DSCAM-AS1 in breast cancer progression

  • Yashar S. Niknafs,
  • Sumin Han,
  • Teng Ma,
  • Corey Speers,
  • Chao Zhang,
  • Kari Wilder-Romans,
  • Matthew K. Iyer,
  • Sethuramasundaram Pitchiaya,
  • Rohit Malik,
  • Yasuyuki Hosono,
  • John R. Prensner,
  • Anton Poliakov,
  • Udit Singhal,
  • Lanbo Xiao,
  • Steven Kregel,
  • Ronald F. Siebenaler,
  • Shuang G. Zhao,
  • Michael Uhl,
  • Alexander Gawronski,
  • Daniel F. Hayes,
  • Lori J. Pierce,
  • Xuhong Cao,
  • Colin Collins,
  • Rolf Backofen,
  • Cenk S. Sahinalp,
  • James M. Rae,
  • Arul M. Chinnaiyan,
  • Felix Y. Feng

DOI
https://doi.org/10.1038/ncomms12791
Journal volume & issue
Vol. 7, no. 1
pp. 1 – 13

Abstract

Read online

LncRNAs have been associated with cancer. Here, the authors carry out a systematic review of lncRNAs in breast cancer and show that DSCAM-AS1is highly expressed in oestrogen receptor positive tumours and enhances cancer through an interaction with hnRNPL; and is also associated with tamoxifen resistance.